openPR Logo
Press release

Social Anxiety Disorder Market Size in the 7MM is anticipated to increase during the Study Period, 2019-2032, estimates DelveInsight

11-17-2023 12:19 PM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Social Anxiety Disorder Market

Social Anxiety Disorder Market

"The Social Anxiety Disorder market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Social Anxiety Disorder pipeline products will significantly revolutionize the Social Anxiety Disorder market dynamics"

The Social Anxiety Disorder market report provides current treatment practices, Social Anxiety Disorder emerging drugs, market share of individual therapies, and current and forecasted 7MM Social Anxiety Disorder market size from 2019 to 2032. The report also covers current Social Anxiety Disorder treatment market practices/algorithms and unmet medical needs to curate the best opportunities and assess the market's underlying potential.

Key Takeaways from the Social Anxiety Disorder Market Report
• The increase in Social Anxiety Disorder market size is a direct consequence of an increase in R&D activity, increasing prevalent population, expected commercial success of upcoming therapies in the US.
• The leading companies working in the Social Anxiety Disorder market include EmpowerPharm Inc., Pherin Pharmaceuticals Inc., Bionomics Limited, GlaxoSmithKline, Receptor Life Sciences, H. Lundbeck A/S, Avera Pharmaceuticals, Pfizer, Cephalon, Duke University, AstraZeneca, VistaGen Therapeutics Inc., Eli Lilly and Company, and others.
• Promising Social Anxiety Disorder Pipeline Therapies in the various stages of development include oral solution, PH94B, 225 mg BNC210, GW679769, Escitalopram, Venlafaxine ER, Paroxetine, AV608, Vestipitant/Paroxetine, and others.
• On February 2023, McMaster University announced a study of Phase 3 Clinical Trials for Oil Capsules and Sunflower Lecithin Oil in Capsule. This proposed study aims to evaluate the efficacy of daily Oil Capsules in treating symptoms of DSM-5 anxiety disorders, using a two-arm, 8-week randomized, placebo-controlled trial in adults aged 21-65 years. The study will also evaluate the relationship between inflammation, anxiety and using biological markers as well as examine the neuro-cognitive effects of treatment.
• On April 2023, Receptor Life Sciences announced a study of Phase 1 Clinical Trials for Low dose RLS103 and High dose RLS103. This is a Phase 1b/2a clinical trial to evaluate the safety, tolerability, and efficacy of RLS103 inhaled dry powder) to relieve the anxiety induced by a public speaking challenge in adults with social anxiety disorder (SAD).
• On May 2023, EmpowerPharm Inc. announced a study of Phase 2 Clinical Trials for Oral Solution. A phase 2, multicenter, double-blind, parallel group, placebo-controlled, randomized clinical study, designed to compare the efficacy, safety, and tolerability of 2 dose levels and a matching placebo for the treatment of subjects with Social Anxiety Disorder (SAD).

Discover more about therapies set to grab major Social Anxiety Disorder Market Share @ Social Anxiety Disorder Market Size- https://www.delveinsight.com/report-store/social-anxiety-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Social Anxiety Disorder Overview
Social Anxiety disorder (SAD), also called Social Phobia, is the most common mental health condition that causes extreme fear in social settings, and an intense, persistent fear of being watched and judged by others.

Social Anxiety Disorder Epidemiology Segmentation in the 7MM
• Social Anxiety Disorder Prevalent Cases
• Social Anxiety Disorder Age-specific Cases
• Social Anxiety Disorder Diagnosed Prevalent Cases
• Social Anxiety Disorder Gender-specific Cases
• Social Anxiety Disorder Severity-specific Cases
• Social Anxiety Disorder Treatable Cases

Download the report to understand which factors are driving Social Anxiety Disorder Epidemiology Trends @ Social Anxiety Disorder Epidemiological Insights- https://www.delveinsight.com/sample-request/social-anxiety-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Social Anxiety Disorder Treatment Market
Social anxiety disorder treatment includes psychological and pharmacological options. The psychological intervention termed cognitive-behavioral therapy (CBT) is used to help patients face barriers directly through exposure techniques, relaxation techniques, and training in social and conversational skills. It is always recommended that CBT should be implemented ahead of pharmacologic therapy. Patients who manage their symptoms with psychological and pharmacologic treatment are more likely to achieve continued symptom-improvement benefits.

Social Anxiety Disorder Market Insights
Despite a lot of options present in the current treatment, there are several unmet needs in the treatment of anxiety disorders including the need for more effective, rapidly acting, and better-tolerated medications; early identification of nonresponse; effective treatments for refractory disorders; prevention of relapse; and promotion of resilience and long-lasting response. Rates of response to contemporary antidepressants and other anxiolytics are often less robust than might be hoped, and remission rates, which have until recently been infrequently measured, are even lower.

To know more about Social Anxiety Disorder Treatment options, visit @ Social Anxiety Disorder Drugs- https://www.delveinsight.com/sample-request/social-anxiety-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Social Anxiety Disorder Market Size
According to DelveInsight's' estimates, the Social Anxiety Disorder market in the US is expected to show a positive growth, during the forecast period (2023-2032), mainly attributed to the anticipated launch of emerging therapy and the increasing cases of Social Anxiety disorder.

Social Anxiety Disorder Market Dynamics
The dynamics of the social anxiety disorder therapeutics market are anticipated to change in the coming years owing to the improvement in the research and development undertaking. Key players such as Vistagen Therapeutics [PH94B], EmpowerPharm [EPI-001], and Bionomics [BNC210], among others in the clinical development stage will lead to a significant increase in the market size during the forecast period [2023-2032].

Learn more about the Social Anxiety Disorder Pipeline Therapies in clinical trials @ Social Anxiety Disorder Market Landscape- https://www.delveinsight.com/sample-request/social-anxiety-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Social Anxiety Disorder Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Social Anxiety Disorder Companies- EmpowerPharm Inc. (NYSE: EPW), Pherin Pharmaceuticals Inc., Bionomics Limited (NYSE: BNOX), GlaxoSmithKline (NYSE: GSK), Receptor Life Sciences, H. Lundbeck A/S (NYSE: HLUN-A.CO), Avera Pharmaceuticals, Pfizer (NYSE: PFE), Cephalon (NYSE: CEPH), Duke University, AstraZeneca (NYSE: AZN), VistaGen Therapeutics Inc. (NYSE: VTGN), Eli Lilly and Company (NYSE: LLY), and others.
• Social Anxiety Disorder Pipeline Therapies- oral solution, PH94B, 225 mg BNC210, GW679769, Escitalopram, Venlafaxine ER, Paroxetine, AV608, Vestipitant/Paroxetine, and others.
• Social Anxiety Disorder Market Dynamics: Social Anxiety Disorder Market Drivers and Barriers
• Social Anxiety Disorder Market Access and Reimbursement, Unmet Needs and Analyst Views

Discover more about Social Anxiety Disorder Drugs in development @ Social Anxiety Disorder Ongoing Clinical Trials Analysis- https://www.delveinsight.com/sample-request/social-anxiety-disorder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Executive Summary of Social Anxiety Disorder
3. Competitive Intelligence Analysis for Social Anxiety Disorder
4. Social Anxiety Disorder Market Overview at a Glance
5. Social Anxiety Disorder Market Disease Background and Overview
6. Patient Journey
7. Social Anxiety Disorder Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Social Anxiety Disorder Unmet Needs
10. Key Endpoints of Social Anxiety Disorder Treatment
11. Social Anxiety Disorder Marketed Products
12. Social Anxiety Disorder Emerging Therapies
13. Social Anxiety Disorder: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Social Anxiety Disorder Market Outlook
16. Access and Reimbursement Overview of Social Anxiety Disorder
17. Social Anxiety Disorder KOL Views
18. Social Anxiety Disorder Market Drivers
19. Social Anxiety Disorder Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

Important Published Links-

https://treadmill.mn.co/posts/45459156
https://chineseintheus.mn.co/posts/parkinsons-disease-market-size-outlook-and-forecast
https://wear.net/dennydones9/
https://productinn.mn.co/posts/parkinsons-disease-market-outlook-and-forecast-report-2032
https://justchatting.mn.co/posts/45460636
https://expressyourcurve.mn.co/posts/45460860
https://clinalleve.mn.co/posts/parkinsons-disease-market-size-outlook-and-forecast-2032
https://nhattao.com/members/user6331540.6331540/
https://seedly.sg/profile/denny-dones/
https://note.com/denny_dones/n/n489e5dd1ff1a
https://www.storeboard.com/JohnSmith-5965202
https://doodleordie.com/profile/dennydones99
https://macro.market/company/delveinsight-business-research
https://pantip.com/profile/7306022#topics
https://allmylinks.com/dennydonesusa
https://uconnect.ae/read-blog/4382
https://blacksnetwork.net/post/102497_herpetic-keratitis-is-a-condition-that-affects-the-eye-and-is-caused-by-the-herp.html
https://ekonty.com/-dennydones99
https://app.wedonthavetime.org/posts/03e285b9-e449-4c96-b257-8cb7a2b74243
https://www.weddingbee.com/members/dennydones99/
https://community.storytellingwithdata.com/members/me/gallery
https://participer.valdemarne.fr/profiles/denny_dones/activity
https://elderassociation.mn.co/posts/45117025
https://www.domestika.org/en/dennydones99
https://nxgen.mn.co/members/19995548
https://www.laclt.com/profile/ybhardwaj/profile
https://stemfemmes.mn.co/posts/emerging-trends-in-managing-hot-flashes-in-the-prostate-cancer-market
https://network-91053.mn.co/posts/45119865
https://autism-support.mn.co/posts/understanding-hot-flashes-in-prostate-cancer-market-size-and-outlook-2032
https://jasa-seo.mn.co/posts/45120226
https://lapp.unl.edu.ec/profiles/dennydones99/activity?locale=en
https://imarticus.org/skillenza/user/dennydones9
https://oppathingzz.mn.co/members/20019648
https://findaspring.org/members/dennydones9/
https://www.poeticous.com/yashveer-bhardwaj
https://git.disroot.org/dennydones9
https://kuula.co/profile/havensmith
https://artmight.com/user/profile/3082810
https://www.credly.com/users/denny-dones/badges
https://quantum-buoyancy.mn.co/posts/axillary-hyperhidrosis-market-size-and-outlook-delveinsight
https://freeline.mn.co/posts/45202136
https://3dwarehouse.sketchup.com/user/0e9f9584-794e-4467-ac59-79db9efbadd9/Denny-Dones
https://www.hackster.io/dennydones9
https://letterboxd.com/dennydones9/
https://ko-fi.com/dennydones9
https://wakelet.com/@DennyDones813
https://onedio.com/profil/dennydones9
https://www.lyrics.com/user/349564/dennydones9#google_vignette
https://hypothes.is/users/dennydones9
https://shivambhu-hut.mn.co/posts/exploring-the-axillary-hyperhidrosis-market-innovations-treatments-and-future-prospects
https://zumvu.com/dennydones9/
https://onlyfans.com/dennydones9
https://maker.wiznet.io/dennydones9
https://collab.sundance.org/people/Denny-Dones-1699939772
https://insurtechasia.mn.co/posts/45403575
https://meganto-lottery.mn.co/posts/45403650
https://ylimun.mn.co/posts/45403740
https://network-79379.mn.co/posts/45404061
https://acatpg.mn.co/posts/45404422
https://brooklynneo.mn.co/posts/45404495
https://ucat-bootcamp.mn.co/posts/45404540
https://coding-playground.mn.co/posts/45404600
https://living-word-network.mn.co/posts/45404653

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers and acquisitions.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Social Anxiety Disorder Market Size in the 7MM is anticipated to increase during the Study Period, 2019-2032, estimates DelveInsight here

News-ID: 3291720 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Social

Social Media Management Market, Social Media Management Market Size, Social Medi …
The Social Media Management Market is growing rapidly as businesses increasingly rely on social platforms to engage with customers, build brand awareness, and drive digital marketing strategies. Social media management solutions help organizations streamline content creation, scheduling, analytics, and audience engagement across multiple platforms, enabling more efficient and effective campaigns. With the rise of data-driven marketing, these tools also provide valuable insights into user behavior, trends, and campaign performance. As
Introducing Waby Social - The Revolutionary Social Networking Platform
Waby Social is proud to announce the launch of its highly anticipated social networking platform, designed to revolutionize the way people interact online. With a focus on user privacy, simplicity, and seamless functionality, Waby Social promises to deliver a new standard of social media experience. Waby Social aims to address the growing concerns of privacy and security issues that have plagued the social media landscape for years. The platform is designed
Global Social Television Market by Types (Sharing Technology, Social EPG/Content …
The Global Social Television Market is expected to reach US$ XX Million by 2026, with a CAGR of XX% from 2021 to 2026, based on a newly published report. Global Social Television Market Overview Social Television Market research report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Global social television is a new form of television that is growing in popularity. Social television
Customer Relationship Management (CRM) Market Report 2018: Segmentation by Socia …
Global Customer Relationship Management (CRM) market research report provides company profile for SAP, Oracle, Salesforce.com, Amdocs, IBM and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation on the
Very social, but not just social media
Which channels are customers’ favourites when it comes to sharing good experiences? By: Graham Ede, Yonder Digital Group “Twice as many people tell others about bad experiences as opposed to the good ones” do you believe in this old adage? If so, you would not be alone, however, latest research commissioned by Yonder Digital Group reveals this common perception is in fact not true. A key game-changer has been the rise of
Trig Social Media announces acquisition of social-commerce.co
Trig social media AB is delighted to announce acquisition of 50.5% of www.social-commerce.co and its holding company Fusion Finance with an option to acquire the remaining 49.5% toward the end of the year. The transaction will be completed with 9 million Trig Social Media shares to be issued shortly. The price for the remaining 49.5% is performance based. Social-commerce is a gamified gig economy platform with an affiliate component that is